On 11 November 2020, Xi’an Jiaotong-Liverpool University launched its new XJTLU Wisdom Lake Academy of Pharmacy.
“The biopharmaceutical industry is one of the fastest-growing sectors worldwide,” says Dr Yimin Ding, Vice President of XJTLU. “A report by the National Bureau of Statistics of China has said it’s an area with huge growth potential. “It is also an exciting industry – with the development of artificial intelligence and nanotechnology, there’s a lot of opportunity for cross-discipline cooperation in the field.”
In addition to the support of the local Suzhou government and various partners in the biopharmaceutical industry, the Academy is bolstered by its connection to the University of Liverpool, one of XJTLU’s parent schools.
The University of Liverpool has an internationally leading Department of Molecular and Clinical Pharmacology, which was awarded with a Queen’s Anniversary Prize in 2017. The two universities plan to partner to establish the XJTLU Offshore Innovation Centre for Emerging Technologies (UK), which will leverage expertise from both institutions.
The Academy, which plans to admit its first cohort of students in 2021, will feature three departments (Pharmaceutical Sciences, Pharmacy, and Biopharmaceuticals), six undergraduate programmes and eight masters and doctoral programmes. The Academy plans to have a total of 2,000 students by 2026.
The key areas of research will be: novel therapeutic drug and strategy development, AI and pharmaceutics, and clinical pharmacy.
The institution will also feature several research centres, such as the Pharmaceutical Informatics and Data Science Institute, the Pharmaceutical Analysis and Testing Centre and the XJTLU-UoL Pharmacology Research Centre, among others.
